Skip to content

Lantheus Holdings LNTH Asset turnover

Asset turnover at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
0.6×0.0×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
0.7×+0.2×
Guardant Health logo
Guardant HealthGH
0.7×+0.2×
Revvity logo
RevvityRVTY
0.2×0.0×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
0.3×+0.2×
Labcorp Holdings logo
Labcorp HoldingsLH
0.8×0.0×

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Calculated from Lantheus Holdings’s reported figures.

Based on trailing twelve months.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's asset turnover?
Lantheus Holdings (LNTH) reported asset turnover of 0.7× in Q1 2026.
How has Lantheus Holdings's asset turnover changed year-over-year?
Lantheus Holdings's asset turnover decreased by 11.2% year-over-year, from 0.8× to 0.7×.
What is the long-term trend for Lantheus Holdings's asset turnover?
Over 5 years (2020 to 2025), Lantheus Holdings's asset turnover has grown at a 6.6% compound annual growth rate (CAGR), from 0.5× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.